ArticleInternational journal of clinical and experimental pathology2018

Expression of hypoxia-inducible factor-1a predicts benefit from rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in diffuse large B-cell lymphoma.

Jie Jin et al.PubMed ↗Full text ↗

No numbers read from the abstract.